| Literature DB >> 28577561 |
Jobert Richie Nansseu1,2, Vicky Jocelyne Ama Moor3,4,5, Ruth Danielle M Takam6, Bertrand Zing-Awona7,8,9, Marcel Azabji-Kenfack4, Francine Tankeu5, Corinne M Tchoula5, Bruno M Moukette5, Jeanne Y Ngogang3,4,6.
Abstract
BACKGROUND: Elevated titers of antibodies against oxidized low-density lipoproteins-cholesterol (ox-LDL-Ab) have been reported among professional athletes, paradoxically reflecting an increased risk of developing atherogenic and/or cardiovascular events. This study aimed to determine titers of ox-LDL-Ab in a group of Cameroonian professional soccer players, and evaluate their evolution during part of a competition season as well as the plasmatic antioxidant status to find out if this latter correlates with ox-LDL-Ab .Entities:
Keywords: Antioxidants; Atherosclerosis; Cameroon; Oxidized low-density lipoproteins; Soccer players
Mesh:
Substances:
Year: 2017 PMID: 28577561 PMCID: PMC5455176 DOI: 10.1186/s13104-017-2508-x
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Overall results of the study participants at each measurement (N = 18)
| Variable | Min | Max | Mean | SD | Median | IQR |
|---|---|---|---|---|---|---|
| Age (years) | 16 | 28 | 20.6 | 3.1 | 19.5 | 19–23 |
| BMI (kg/m2) | 21.4 | 25.8 | 23.4 | 1.3 | 23.3 | 22.4–24.4 |
| Total cholesterol 1 (mg/dl) | 87 | 186 | 135 | 22 | 136 | 123–145 |
| Total cholesterol 2 (mg/dl) | 125 | 193 | 156 | 18 | 155 | 142–169 |
| Total cholesterol 3 (mg/dl) | 118 | 203 | 161 | 23 | 161 | 145–177 |
| Triglycerides 1 (mg/dl) | 61 | 138 | 84 | 21 | 76 | 69–99 |
| Triglycerides 2 (mg/dl) | 59 | 114 | 81 | 17 | 79 | 69–91 |
| Triglycerides 3 (mg/dl) | 68 | 127 | 96 | 19 | 93 | 83–116 |
| HDL-C 1 (mg/dl) | 35 | 85 | 63 | 13 | 64 | 51–72 |
| HDL-C 2 (mg/dl) | 53 | 90 | 66 | 11 | 65 | 55–72 |
| HDL-C 3 (mg/dl) | 40 | 81 | 58 | 11 | 58 | 49–63 |
| LDL-C 1 (mg/dl) | 20 | 101 | 56 | 20 | 55 | 41–69 |
| LDL-C 2 (mg/dl) | 38 | 104 | 74 | 19 | 79 | 56–87 |
| LDL-C 3 (mg/dl) | 50 | 134 | 82 | 21 | 81 | 70–96 |
| ox-LDL-Ab1 (mIU/ml) | 379.52 | 1786.20 | 724.69 | 366.65 | 653.32 | 468.18–838.80 |
| ox-LDL-Ab2 (mIU/ml) | 197.52 | 1494.34 | 832.10 | 377.54 | 777.73 | 553.71–1150.74 |
| ox-LDL-Ab3 (mIU/ml) | 284.78 | 2640.76 | 1198.67 | 564.05 | 1037.68 | 901.74–1481.46 |
| Uric acid 1 (mg/l) | 32.45 | 115.47 | 61.67 | 20.05 | 58.11 | 49.05–70.00 |
| Uric acid 2 (mg/l) | 26.46 | 63.38 | 48.44 | 9.58 | 48.51 | 41.98–54.27 |
| Uric acid 3 (mg/l) | 42.84 | 86.81 | 57.54 | 10.87 | 56.74 | 48.39–63.97 |
| FRAP 1 (mmol/l) | 0.405 | 0.658 | 0.539 | 0.082 | 0.537 | 0.469–0.613 |
| FRAP 2 (mmol/l) | 0.285 | 0.597 | 0.441 | 0.084 | 0.451 | 0.397–0.488 |
| FRAP 3 (mmol/l) | 0.204 | 0.616 | 0.470 | 0.126 | 0.503 | 0.363–0.575 |
| GSH 1 (µmol/l) | 1.20 | 7.35 | 3.71 | 1.61 | 3.08 | 2.61–4.83 |
| GSH 2 (µmol/l) | 1.39 | 6.61 | 3.38 | 1.40 | 3.05 | 2.44–4.39 |
| GSH 3 (µmol/l) | 1.98 | 7.94 | 3.84 | 1.42 | 3.64 | 2.72–4.46 |
| SOD 1 (IU/ml) | 4.95 | 26.45 | 15.35 | 6.70 | 17.25 | 8.27–20.99 |
| SOD 2 (IU/ml) | 5.63 | 26.45 | 14.23 | 6.62 | 14.38 | 7.60–20.11 |
| SOD 3 (IU/ml) | 4.44 | 29.90 | 18.05 | 8.57 | 21.25 | 6.88–24.44 |
Min minimum, Max maximum, SD standard deviation, IQR inter quartile range, BMI body mass index
Comparison of variables between the 3 measurements (T1, T2 and T3)
| Comparison | p valuea | Overall comparison (p value)b |
|---|---|---|
| Total cholesterol 1–total cholesterol 2 |
| |
| Total cholesterol 2–total cholesterol 3 | 0.257 |
|
| Total cholesterol 1–total cholesterol 3 |
| |
| Triglycerides 1–triglycerides 2 | 0.794 | |
| Triglycerides 2–triglycerides 3 |
| 0.061 |
| Triglycerides 1–triglycerides 3 | 0.094 | |
| HDL-C 1–HDL-C 2 | 0.381 | |
| HDL-C 2–HDL-C 3 | 0.089 | 0.192 |
| HDL-C 1–HDL-C 3 | 0.107 | |
| LDL-C 1–LDL-C 2 |
| |
| LDL-C 2–LDL-C 3 | 0.064 |
|
| LDL-C 1–LDL-C 3 |
| |
| ox-LDL-Ab 1–ox-LDL-Ab 2 | 0.122 | |
| ox-LDL-Ab 2–ox-LDL-Ab 3 |
|
|
| ox-LDL-Ab 1–ox-LDL-Ab 3 |
| |
| Uric acid 1–uric acid 2 |
| |
| Uric acid 2–uric acid 3 |
|
|
| Uric acid 1–uric acid 3 | 0.557 | |
| FRAP 1–FRAP 2 |
| |
| FRAP 2–FRAP 3 | 0.528 |
|
| FRAP 1–FRAP 3 |
| |
| GSH 1–GSH 2 | 0.663 | |
| GSH 2–GSH 3 | 0.206 | 0.115 |
| GSH 1–GSH 3 | 0.306 | |
| SOD 1–SOD 2 | 0.170 | |
| SOD 2–SOD 3 |
| 0.110 |
| SOD 1–SOD 3 | 0.065 |
* p value <0.05
aThese 2-paired comparisons were performed using the Wilcoxon test
bThese are the results of overall comparisons of the 3 measurements using the Friedman test
Fig. 1Variation of oxidized Low-Density-Lipoprotein antibodies (ox-LDL-Ab) titer between the three measurements. From T1 to T3, we observed a significant rise in oxidized LDL antibodies titers (p = 0.006)
Correlations between oxidized LDL antibodies (ox-LDL-Ab) and the other parameters at the three samplings (T1, T2 and T3)
| Sampling | Correlation between ox-LDL-Ab and | Coefficient of correlation (ρ) | p value |
|---|---|---|---|
| T1 | Total cholesterol | 0.316 | 0.201 |
| Triglycerides | −0.138 | 0.586 | |
| HDL | 0.026 | 0.919 | |
| LDL | 0.368 | 0.133 | |
| Uric acid | 0.047 | 0.855 | |
| FRAP | −0.413 | 0.089 | |
| GSH | 0.241 | 0.336 | |
| SOD | 0.136 | 0.591 | |
| T2 | Total cholesterol | 0.197 | 0.434 |
| Triglycerides | −0.115 | 0.650 | |
| HDL |
|
| |
| LDL | −0.146 | 0.564 | |
| Uric acid | −0.094 | 0.711 | |
| FRAP | 0.277 | 0.266 | |
| GSH | 0.164 | 0.515 | |
| SOD |
|
| |
| T3 | Total cholesterol | −0.218 | 0.385 |
| Triglycerides | 0.003 | 0.990 | |
| HDL | 0.085 | 0.738 | |
| LDL | −0.250 | 0.317 | |
| Uric acid | −0.123 | 0.627 | |
| FRAP | −0.212 | 0.399 | |
| GSH | 0.100 | 0.692 | |
| SOD | 0.085 | 0.738 |
* p value <0.05
Results of the mixed linear regression model analysis with oxidized low-density lipoproteins (ox-LDL-Ab) as the dependent variable
| Variable | Value (β) | Standard error | p value |
|---|---|---|---|
| Visit |
|
|
|
| Uric acid | 7.53 | 4.47 | 0.1037 |
| HDL | 714.81 | 478.78 | 0.1470 |
| LDL | 377.35 | 312.03 | 0.2370 |
| Triglycerides | −38.55 | 322.16 | 0.9056 |
| FRAP | 129.60 | 608.49 | 0.8329 |
| GSH | 59.49 | 40.86 | 0.1569 |
| SOD |
|
|
|
| Age | 26.41 | 21.86 | 0.2445 |
* p < 0.05